Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses
NCT ID: NCT06892470
Last Updated: 2025-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
62 participants
OBSERVATIONAL
2025-03-01
2026-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing Monofocal IOLs in Highly Myopic Cataract Patients
NCT06905938
Visual Outcomes of Functional Intraocular Lenses in Cataracts
NCT06092164
Visual Performance of Functional Intraocular Lenses in Cataracts
NCT05581888
Visual Quality Change of Eyes Implanted With Diffractive Multifocal Intraocular Lens After Cataract Surgery
NCT02234635
Visual Outcomes of an Enhanced Monofocal Intraocular Lens Targeted for Monovision in Highly Myopic Eyes: a Randomized Controlled Trial
NCT07168109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TNF Group:
Implantation of PanOptix trifocal IOL
No intervention
No intervention
ZFR Group:
Implantation of Tecnis Symfony ZFR00 extended depth of focus IOL (Johnson \& Johnson)
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2: The axial length (AL) measured by IOLMaster 700 is ≥26 mm
3: No anterior or posterior segment pathology that could potentially compromise visual potential (such as glaucoma, myopic traction maculopathy, corneal leukoma, etc.).
4: Able to understand, cooperate, and complete all follow - ups
Exclusion Criteria
2: Retinal detachment in the same eye or the fellow eye
3: Presence of multiple peripheral retinal degenerative changes
4: History of previous ocular surgery
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wenzhou Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yune Zhao
Vice president of Eye Hospital of Wenzhou Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ophthalmology and Optometry Hos
Hanzhou, Zhejian, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H2025-015-K-14-04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.